Health Condition 1: null- ASA I and II patients Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 60 ASA (American Society of Anaesthesiologists) I-II female patients in the age group of 18-60 years 2. scheduled to undergo total mastectomy with axillary clearance under general anaesthesia will be enrolled in the study.
Exclusion criteria
Exclusion criteria: 1. Local infection at the block site 2. Coagulopathy 3. Morbid obesity (BMI >40) 4. Allergy to local anaesthetics 5. Uncontrolled hypertension or Ischemic heart disease 6. Renal dysfunction 7. Pre-existing neurological deficits 7. Psychiatric illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is to measure analgesic efficacy of erector spinae plane block in terms of morphine consumption in the first 24 hours in patients undergoing total mastectomy and axillary clearance under erector spinae plane block with general anaesthesia and general anaesthesia alone.Timepoint: at 24 hours post operatively total morphine consumption will be recorded | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary aims are to compare the time to first rescue analgesia, pain scores as assessed by Numerical Rating Scale (NRS) in the two groups and to evaluate the characteristics & complications associated with the block procedure.Timepoint: postoperative period at 0min 30 min 1 hr 2hr 4hr 6hr 8hr 12hr and 24hr | — |
Countries
India
Contacts
Postgraduate Institute of Medical Education and Research